Patents by Inventor Andrew Whitney

Andrew Whitney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10245268
    Abstract: Provided herein are methods, compositions, and kits for treating ACVR-1-mediated diseases using N-(cyanomethyl)-4-[2-4-morpholinoanilino)pyrimidin-4-yl]benzamide.
    Type: Grant
    Filed: August 8, 2017
    Date of Patent: April 2, 2019
    Assignee: Sierra Oncology, Inc.
    Inventors: Brian Koh, Igor Theurl, Matthew Robert Warr, James Andrew Whitney
  • Publication number: 20180256200
    Abstract: A system for endoscopic ultrasound guided drainage includes an access sheath including an elongated tube extending longitudinally from a proximal end to a distal end and including an access lumen extending therethrough from the proximal end to the distal end and a flexible tip coupled to the distal end of the elongated tube, the flexible tip biased to a curved configuration. The system also includes a sharp slidably received within the access lumen, the sharp extending longitudinally from a proximal end to distal end and including a channel extending therethrough, the channel configured to receive a fluid therethrough. In addition, the system includes a dilating sheath extending longitudinally from a proximal end to a distal end and including a dilating lumen extending therethrough, the dilating lumen sized and shaped to slidably receive the access sheath. The dilating lumen is sized and shaped to slidably receive the access sheath.
    Type: Application
    Filed: March 6, 2018
    Publication date: September 13, 2018
    Inventors: Christopher Benning, Raymond Gessler, III, Jessica Phelan, Kushal Palkhiwala, Bryan Bannon, Peter Dayton, Andrew Whitney
  • Publication number: 20180042933
    Abstract: Provided herein are methods, compositions, and kits for treating ACVR-1-mediated diseases using N-(cyanomethyl)-4-[2-4-morpholinoanilino)pyrimidin-4-yl]benzamide.
    Type: Application
    Filed: August 8, 2017
    Publication date: February 15, 2018
    Inventors: Brian Koh, Igor Theurl, Matthew Robert Warr, James Andrew Whitney
  • Patent number: 9809559
    Abstract: The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: November 7, 2017
    Assignee: GILEAD SCIENCES, INC.
    Inventors: Brandon H. Brown, Ernest A. Carra, Jeffrey N. Hemenway, Henry Morrison, Troy Reynolds, Bing Shi, Dimitrios Stefanidis, Fang Wang, Matthew Robert Warr, James Andrew Whitney, Yan Xin
  • Publication number: 20160347719
    Abstract: The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.
    Type: Application
    Filed: August 8, 2016
    Publication date: December 1, 2016
    Inventors: Brandon H. Brown, Ernest A. Carra, Jeffrey N. Hemenway, Henry Morrison, Troy Reynolds, Bing Shi, Dimitrios Stefanidis, Fang Wang, Matthew Robert Warr, James Andrew Whitney, Yan Xin
  • Publication number: 20160320162
    Abstract: Described herein are armour panels that can be used to protect entities such as vehicles, buildings or organisms from overpressure either in the form of an explosion (shockwave) or projectile (bullet, shrapnel etc). In particular, the invention relates to the use of a combination of layers to form a panel with pressure impulse mitigating properties to provide an armour panel which is lightweight, cheap to manufacture and yet strong enough to withstand impact from high velocity ballistics, fragments and the like.
    Type: Application
    Filed: March 18, 2016
    Publication date: November 3, 2016
    Applicant: BioDynamic Armor Ltd
    Inventors: Andrew WHITNEY, Len TARASOFF
  • Patent number: 9469613
    Abstract: The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.
    Type: Grant
    Filed: June 11, 2015
    Date of Patent: October 18, 2016
    Assignee: GILEAD SCIENCES, INC.
    Inventors: Brandon H. Brown, Ernest A. Carra, Jeffrey N. Hemenway, Henry Morrison, Troy Reynolds, Bing Shi, Dimitrios Stefanidis, Fang Wang, Matthew Robert Warr, James Andrew Whitney, Yan Xin
  • Publication number: 20160279135
    Abstract: Provided herein are methods, compositions, and kits for treating myeloproliferative disorders or neoplasms, including polycythemia vera, primary myelofibrosis, thrombocythemia, and essential thrombocythemia.
    Type: Application
    Filed: June 8, 2016
    Publication date: September 29, 2016
    Inventors: Brian Lannutti, Sarah Meadows, Christophe Queva, Matthew Robert Warr, James Andrew Whitney
  • Patent number: 9347745
    Abstract: A multilayer armored panel comprising: (I) at least one layer that is non moldable when dry but moldable when wet; (II) at least one hydrogel based layer in contact with layer (I) which, when wet enables the molding of layer (I) but which is capable of drying out to leave a non moldable layer (I).
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: May 24, 2016
    Assignee: BIODYNAMIC ARMOR LTD
    Inventor: Andrew Whitney
  • Publication number: 20150361050
    Abstract: The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.
    Type: Application
    Filed: June 11, 2015
    Publication date: December 17, 2015
    Inventors: Brandon H. Brown, Ernest A. Carra, Jeffrey N. Hemenway, Henry Morrison, Troy Reynolds, Bing Shi, Dimitrios Stefanidis, Fang Wang, Matthew Robert Warr, James Andrew Whitney, Yan Xin
  • Publication number: 20150198424
    Abstract: A multilayer armored panel comprising: (I) at least one layer that is non moldable when dry but moldable when wet; (II) at least one hydrogel based layer in contact with layer (I) which, when wet enables the moulding of layer (I) but which is capable of drying out to leave a non moldable layer (I).
    Type: Application
    Filed: August 2, 2013
    Publication date: July 16, 2015
    Inventor: Andrew Whitney
  • Publication number: 20150148345
    Abstract: Provided herein are methods, compositions, and kits for treating myeloproliferative disorders or neoplasms, including polycythemia vera, primary myelofibrosis, thrombocythemia, and essential thrombocythemia.
    Type: Application
    Filed: November 25, 2014
    Publication date: May 28, 2015
    Inventors: Brian Lannutti, Sarah Meadows, Christophe Queva, Matthew Robert Warr, James Andrew Whitney
  • Publication number: 20140265313
    Abstract: Adapters for attaching a device to a port and methods of use thereof are disclosed. The adapter may include a housing to receive the device, wherein the housing includes an inner cavity configured to receive the port, and a sealing member; and an engaging member coupled to and moveable relative to the housing, the engaging member configured to move between a first position and a second position, where in the first position the engaging member locks the housing to the port, and in the second position the engaging member unlocks the housing from the port.
    Type: Application
    Filed: March 11, 2014
    Publication date: September 18, 2014
    Applicant: Boston Scientific Scimed, Inc.
    Inventors: Bernadette DURR, Molly PHILLIPS-HUNGERFORD, Andrew WHITNEY, Farah KHAN, Chris BENNING
  • Publication number: 20120197157
    Abstract: A biopsy device includes a needle extending longitudinally from a proximal end to a distal end and including a channel extending therethrough and a stylet extending through the channel of the needle and including a coil at a distal end thereof such that rotation of the stylet relative to the needle moves the coil from a closed configuration in the channel to a tissue collecting configuration in which the coil extends distally past the distal end of the needle to be inserted into a target tissue.
    Type: Application
    Filed: January 31, 2012
    Publication date: August 2, 2012
    Inventors: Shawn Ryan, Caroline Gaudet, Kayla Burnim, Andrew Whitney, Barry Weitzner
  • Publication number: 20110230878
    Abstract: A device for use in conjunction with a medical device comprises a handle extending longitudinally from a proximal end to a distal end and including a lumen extending therethrough for accommodating a longitudinal probe. A distal end of the handle including a coupling for attachment to a proximal end of a needle device. The handle includes a length adjusting mechanism enabling a user to set a length of the handle at a desired length and a flexible probe sized and shaped for insertion through a lumen of the medical device. A length of the probe is selected relative to a length of the lumen within which it is to be employed so that, when the length of the handle is set at a desired length, insertion of the flexible probe through the lumen to a distal-most position extends a distal portion of the probe distally beyond the distal end of the lumen by a desired distance.
    Type: Application
    Filed: March 2, 2011
    Publication date: September 22, 2011
    Inventors: Shawn Ryan, Caroline Gaudet, Andrew Whitney
  • Patent number: RE48285
    Abstract: The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.
    Type: Grant
    Filed: October 18, 2018
    Date of Patent: October 27, 2020
    Assignee: Sierra Oncology, Inc.
    Inventors: Brandon H. Brown, Ernest A. Carra, Jeffrey N. Hemenway, Henry Morrison, Troy Reynolds, Bing Shi, Dimitrios Stefanidis, Fang Wang, Matthew Robert Warr, James Andrew Whitney, Yan Xin
  • Patent number: RE49445
    Abstract: The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.
    Type: Grant
    Filed: September 4, 2020
    Date of Patent: March 7, 2023
    Assignee: Sierra Oncology, Inc.
    Inventors: Brandon H. Brown, Ernest A. Carra, Jeffrey N. Hemenway, Henry Morrison, Troy Reynolds, Bing Shi, Dimitrios Stefanidis, Fang Wang, Matthew Robert Warr, James Andrew Whitney, Yan Xin